Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
Background/Objective: Our objective was to measure for racial/ethnic disparity among pediatric T1D patientʼs utilization of continuous glucose monitoring (CGM) and insulin pump (IP) technology at Nationwide Childrenʼs Hospital (NCH).
Methods: A multidisciplinary team was assembled to define, measure, and identify any disparity gap. For 9 months we measured technology use among monthly ambulatory clinic attendance of T1D patients with duration of T1D ≥12 months.
Results: Rate of patient utilization of IP technology was 31 patients per 100 visits. Compared among this 31% aggregate mean, White users averaged 37% (higher use); while Hispanic users were lower at 19% and non-Hispanic black patients use was much lower, averaging only 9%. Rate of patient utilization of CGM technology was 62 patients per 100 visits. Compared among this 62% aggregate mean, White users averaged 66% use (higher); while Hispanic users were lower at 53% and non-Hispanic black patients were much lower, averaging only 19%.
This site uses Akismet to reduce spam. Learn how your comment data is processed.